FORM 8.3 - ALLERGAN PLC

LONDON--()-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Allergan plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BY9D5467

Date of dealing

31 January 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class ofrelevant security dealt in(Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

3,576,788 (1.089%)

1,890

(0.001%) 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

3,576,788 (1.089%)

1,890

(0.001%) 

(b) Interests and short positionsin relevant securitiesof the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

(USD)

Purchase

4,403

186.64

Sale

421

186.71

Sale

102

186.82

Sale

384

186.83

Sale

421

186.86

Sale

419

186.87

Sale

550

186.94

Sale

17

187.00

Sale

428

187.14

Sale

393

187.20

Purchase

56,247

186.64

Sale

24,102

186.64

Purchase

24,102

186.64

Purchase

100

186.69

Purchase

150

186.72

Purchase

100

186.74

Purchase

22

186.82

Purchase

300

186.96

Purchase

874

187.01

Purchase

100

187.03

Purchase

16

187.19

Sale

57,552

186.64

Sale

100

186.79

Sale

1,433

186.82

Sale

100

186.83

Sale

100

186.92

Sale

100

187.00

Sale

62

187.04

Sale

59

187.08

Sale

100

187.11

Sale

111

187.12

Sale

22

187.22

Sale

5

187.26

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasingor varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure

3 February 2020

Contact name

Milos Naumovic

Telephone number

+44 203 650 8203

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

Short Name: MILLENNIUM PARTNERS, L.P.
Category Code: RET
Sequence Number: 691675
Time of Receipt (offset from UTC): 20200203T145924+0000

Contacts

Millennium Partners, L.P.

Contacts

Millennium Partners, L.P.